| 英文名称 | Anti-B7-H3 (enoblituzumab biosimilar) mAb |
|---|---|
| 中文名称 | 恩比利珠单抗 |
| CAS号 | 1353485-38-7 |
| 英文名称 | Anti-B7-H3 (enoblituzumab biosimilar) mAb |
|---|---|
| 中文名称 | 恩比利珠单抗 |
| CAS号 | 1353485-38-7 |
Enoblituzumab (Anti-B7-H3 / CD276) is a humanized IgG1κ monoclonal antibody targeting human B7-H3 protein. It can be used in the treatment of medullary thyroid cancer (MTC). MW :150 KD.